This device is indicated for the treatment of chronic atrial fibrillation:
Featuring the core "Synergy" technology to achieve full transmural ablation.
The parallel jaw design ensures complete tissue clamping with high stability.
The information on this page is only for drug information introduction, not for drug advertisement. For detailed prescription information, please refer to the latest version approved by NMPA. The product information on this website should not be used as a substitute for medical advice and medical consultation provided by a physician or other qualified medical professional and should not be used for the diagnosis of a disease. Please click OK to enter.
